These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 45041)

  • 1. Is a slow reacting substance-like compound involved in rat platelet agglutination.
    Meringolo C; Bartolini G; Orlandi M; Tomasi V; Barnabei O
    Prostaglandins Med; 1979 May; 2(5):381-92. PubMed ID: 45041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products.
    Lapetina EG; Chandrabose KA; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):818-22. PubMed ID: 204935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin.
    Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI
    Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of prostaglandin biosynthetic pathways in rat pancreatic islets.
    Kelly KL; Laychock SG
    Prostaglandins; 1984 Jun; 27(6):925-38. PubMed ID: 6435185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some properties of mouse platelets.
    Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
    Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electronic aggregometer: a novel device for assessing platelet behavior in blood.
    Cardinal DC; Flower RJ
    J Pharmacol Methods; 1980 Feb; 3(2):135-58. PubMed ID: 7392654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
    Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
    J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of a slow-reacting substance from rabbit platelets.
    Mencia-Huerta JM; Hadji L; Benveniste J
    J Clin Invest; 1981 Dec; 68(6):1586-91. PubMed ID: 6119324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.